NCT06345703View on ClinicalTrials.gov

First-into-human Study of NS-136 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

February 28, 2025

Conditions
Healthy Subjects
Interventions
DRUG

Placebo

NS-136 matching placebo

DRUG

NS-136 tablet

Investigational product NS-136

Trial Locations (2)

5000

RECRUITING

CMAX Clinical Research Pty Ltd, Adelaide

610000

RECRUITING

Chengdu Xinhua Hospital, Chengdu

Sponsors
All Listed Sponsors
lead

NeuShen Therapeutics

INDUSTRY

NCT06345703 - First-into-human Study of NS-136 in Healthy Subjects | Biotech Hunter | Biotech Hunter